Loading clinical trials...

Executive Function in Obese | Clinical Trials | Clareo Health

RECRUITING

Executive Function in Obese

Effects of Executive Dysfunction on Physical Performance and General Well-Being in Obese Individuals

NCT06578091•Kutahya Health Sciences University

Summary

This study was planned to examine the effect of executive function problems on physical performance and general well-being in obese individuals.

Eligibility

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•For the study group;
•Individuals volunteering for the study with BMI ≥30 kg/m2
•Individuals between the ages of 18-65 who volunteer to work
•Individuals who scored 21 points and above in the cognitive assessment
•For the control group;
•Individuals volunteering for the study with BMI ≥30 kg/m2
•Individuals between the ages of 18 and 65 who are willing to work
•Scoring less than 21 points on the cognitive assessment

Exclusion Criteria

•Being at a mental level that cannot understand and answer the questions posed
•Having a diagnosed neurological disease
•Having had cancer within the last 2 years
•Having major organ dysfunction
•Having uncontrolled type 2 diabetes
•Loss of vision, hearing

Locations (1)

Kutahya Health Sciences University

Kütahya, Central, Turkey (Türkiye)

Key Dates

Start Date

January 30, 2025

Primary Completion Date

November 30, 2026

Completion Date

December 1, 2026

Last Updated

March 10, 2026

Enrollment

100

ESTIMATED participants

Conditions

Obesity

Contacts

İsmail Okur, Assist. Prof.

CONTACT

+905552436726 ismail.okur@ksbu.edu.tr

Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women

NCT07472881

MenopausePerimenopause+2 more

View study

RECRUITING

Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

NCT01143454

Metabolic DiseaseObesity+4 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 10, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Executive Function in Obese

Inclusion Criteria

Exclusion Criteria

Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women

Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial

Protein Supplementation Intervention on Body Weight

Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose

iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss